Fondaparinux

Category: Blood Thinner (Anticoagulant)



Fondaparinux Overview

Fondaparinux (trade name Arixtra) is an anticoagulant medication chemically related to low molecular weight heparins. It is marketed by GlaxoSmithKline. A generic version developed by Alchemia is marketed within the US by Dr. Reddy's Laboratories. Contents 1 Medical uses 1.1 Administration 1.2 Comparison to other agents 2 Pharmacology 2.1 Mechanism of action 3 Chemistry 3.1 Abbreviations 4 References 5 External links Medical uses Clinically, it is used for the prevention of ...

Read more Fondaparinux Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fondaparinux

Recent Fondaparinux Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fondaparinux
  • Injection: 10mg/0.8ml, 2.5mg/0.5ml, 5mg/0.4ml, 7.5mg/0.6ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Fondaparinux: (24 results)

Showing the first 20, Sorted by National Drug Code
  • 43598-606 Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection by Dr. Reddy's Laboratories Inc.
  • 43598-607 Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection by Dr. Reddy's Laboratories Inc.
  • 43598-608 Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection by Dr. Reddy's Laboratories Inc.
  • 43598-609 Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection by Dr. Reddy's Laboratories Inc.
  • 55111-678 Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection by Dr. Reddy's Laboratories Limited
  • 55111-679 Fondaparinux Sodium 5 mg/4ml Subcutaneous Injection by Dr. Reddy's Laboratories Limited
  • 55111-680 Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection by Dr. Reddy's Laboratories Limited
  • 55111-681 Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection by Dr. Reddy's Laboratories Limited
  • 55150-230 Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection, Solution by Auromedics Pharma LLC
  • 55150-231 Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection, Solution by Auromedics Pharma LLC
  • 55150-232 Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection, Solution by Auromedics Pharma LLC
  • 55150-233 Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection, Solution by Auromedics Pharma LLC
  • 60505-6078 Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection, Solution by Apotex Corp.
  • 60505-6079 Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection, Solution by Apotex Corp.
  • 60505-6080 Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection, Solution by Apotex Corp.
  • 60505-6081 Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection, Solution by Apotex Corp.
  • 67457-582 Fondaparinux Sodium 2.5 mg/.5ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-583 Fondaparinux Sodium 5 mg/.4ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-584 Fondaparinux Sodium 7.5 mg/.6ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 67457-585 Fondaparinux Sodium 10 mg/.8ml Subcutaneous Injection, Solution by Mylan Institutional LLC
  • 4 more results ...

Other drugs which contain Fondaparinux or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA